Galderma Group AG Unsponsored ADR (GALDY)
OTC
Real-time Data
01:30 PM
Day's Range
42.5452 wk Range
33.13Overview - GALDY - Galderma Group AG Unsponsored ADR
Key Statistics
Valuation
Enterprise Value
51.79B
P/E (Trailing)
‪58.64‬
P/E (Forward)
‪6.76‬
PEG Ratio
‪6.76‬
Price / Sales (TTM)
‪8.42‬
Price / Book
‪6.07‬
EV / EBITDA
‪37.36‬
Profitability
Profit Margin
‪14.57%‬
Operating Margin
‪20.23%‬
Return on Assets
‪5.35%‬
Return on Equity
‪10.82%‬
Ownership
Shares Outstanding
234.56M
Float
656.33M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.01%‬
Price stats
Beta
‪-0.09‬
50-Day Avg
‪43.27‬
200-Day Avg
‪40.66‬
Dividends
Payout Ratio
‪12.13%‬
Frequency
Annual
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GALDY - Galderma Group AG Unsponsored ADR
Peers - GALDY - Galderma Group AG Unsponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - GALDY - Galderma Group AG Unsponsored ADR
About
Galderma Group AG Unsponsored ADR represents a special equity instrument, allowing United States investors to invest in this Switzerland-based dermatology company without trading directly on foreign exchanges. As an unsponsored American Depositary Receipt, it is issued by a depositary bank, allowing the ADR to be…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
